Regencell Bioscience Ownership | Who Owns Regencell Bioscience?


OverviewForecastChart

Regencell Bioscience Ownership Summary


Regencell Bioscience is owned by 0.02% institutional investors, 88.55% insiders, and 11.43% retail investors. Discovery capital management, llc / ct is the largest institutional shareholder, holding 0.35% of RGC shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Regencell Bioscience shares.

RGC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRegencell Bioscience0.02%88.55%11.43%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustrySpecialty & Generic Drug Manufacturers Stocks21.33%14.37%64.29%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Discovery capital management, llc / ct46.17K0.35%$713.26K
Geode capital management415.57K0.08%$10.57M
Vident advisory29.59K0.01%$752.42K
Squarepoint ops26.61K0.01%$676.77K
Ubs group23.89K0.00%$607.40K
Morgan stanley20.08K0.00%$510.58K
State street11.85K0.00%$301.37K
Legal & general group9.90K0.00%$251.83K
Blackrock238.000.00%$800.00
Lpl financial8.60K0.00%$218.60K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Discovery capital management, llc / ct46.17K0.04%$713.26K
Vident advisory29.59K0.01%$752.42K
Squarepoint ops26.61K0.00%$676.77K
Geode capital management415.57K0.00%$10.57M
Eversource wealth advisors452.000.00%$18.29K
Gf fund management1.06K0.00%$27.06K
Federation des caisses desjardins du quebec2.23K0.00%$56.73K
Legal & general group9.90K0.00%$251.83K
Ronald blue trust216.000.00%$5.49K
Bell investment advisors20.000.00%$509.00

Top Buyers

HolderShares% AssetsChange
Discovery capital management, llc / ct46.17K0.04%46.17K
State street11.85K-11.85K
Legal & general group9.90K0.00%9.90K
Lpl financial8.60K0.00%8.60K
Ubs group23.89K0.00%5.68K

Top Sellers

HolderShares% AssetsChange
Schonfeld strategic advisors---52.10K
Gsa capital partners llp---31.57K
Xtx topco---15.08K
Hudson bay capital management lp---13.11K
Y-intercept (hong kong)---13.04K

New Positions

HolderShares% AssetsChangeValue
Discovery capital management, llc / ct46.17K0.04%46.17K$713.26K
State street11.85K-11.85K$301.37K
Legal & general group9.90K0.00%9.90K$251.83K
Lpl financial8.60K0.00%8.60K$218.60K
Federation des caisses desjardins du quebec2.23K0.00%2.23K$56.73K

Sold Out

HolderChange
Gamma investing-8.00
Qube research-13.00
Raymond james financial-71.00
Farther finance advisors-201.00
Simplex trading-217.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202613-38.10%76,539-86.04%-125.88%10-16.67%1-83.33%
Dec 31, 202510-52.38%485,100-23.46%-0.41%6-53.85%3-40.00%
Sep 30, 20252161.54%633,811-3.78%419.01%13-5-
Jun 30, 202513160.00%691,5287731.57%5115339.76%13225.00%--100.00%
Mar 31, 2025566.67%8,830-72.02%-115.38%4100.00%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index300.32K0.06%-
Fidelity Nasdaq Composite ETF121.92K0.02%-
Amundi Prime Global ETF Dist45.23K0.01%-
Undrly Future World Global Equity Idx Lf21.77K0.00%21.77K
L&G Asia Pacific ex Japan Equity ETF17.73K0.00%-
Amundi Prime All Country World ETF Inc15.96K0.00%-
CIBC US Broad Market Index15.29K0.00%-
Undrly Fid DC L&G Fut Wld Mlt Asst MAGJ15.10K0.00%15.10K
Undrly Future Wld Glb Eq Idx GBP Hdg Lf10.34K0.00%10.34K
TD International Equity Index ETF9.60K0.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 29, 2017BELL THOMAS D JR-Buy$369.00K
Aug 25, 2017KAPLAN STEPHEN A-Buy$148.70K
Aug 24, 2017Ownby David EVP, CFO and TreasurerBuy$105.30K
Mar 09, 2017BRANDOW PETER B EVP, General Counsel, Sec.Sell$455.24K
Mar 09, 2017DUNN GREGORY W President and COOSell$577.01K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2018 Q1--
2017 Q4--
2017 Q33-

RGC Ownership FAQ


Who Owns Regencell Bioscience?

Regencell Bioscience shareholders are primarily institutional investors at 0.02%, followed by 88.55% insiders and 11.43% retail investors. The average institutional ownership in Regencell Bioscience's industry, Specialty & Generic Drug Manufacturers Stocks, is 21.33%, which Regencell Bioscience falls below.

Who owns the most shares of Regencell Bioscience?

Regencell Bioscience’s largest shareholders are Discovery capital management, llc / ct (46.17K shares, 0.35%), Geode capital management (415.57K shares, 0.08%), and Vident advisory (29.59K shares, 0.01%). Together, they hold 0.44% of Regencell Bioscience’s total shares outstanding.

Does Blackrock own Regencell Bioscience?

Yes, BlackRock owns 0.00% of Regencell Bioscience, totaling 238 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 800$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Regencell Bioscience’s biggest shareholder by percentage of total assets invested?

Discovery capital management, llc / ct is Regencell Bioscience’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 46.17K Regencell Bioscience shares, valued at 713.26K$.

Who is the top mutual fund holder of Regencell Bioscience shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Regencell Bioscience shares, with 0.06% of its total shares outstanding invested in 300.32K Regencell Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools